公司资料
Cerus Corporation 股价、新闻与催化剂
- 股票代码:
- CERS
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
2.66 USD (+5.14%)
收盘价
最后更新: 2026年9月17日
541M USD
市值
股价为何变动
截至 2026年9月17日，CERS 上涨 5.14%，收于 $2.66。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
业务概览
Cerus is a blood-safety company focused on pathogen-reduction technology for platelets, plasma, and red blood cells. Its business is centered on making transfusions safer through a proprietary platform.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Cerus sits in blood products and healthcare infrastructure.
商业模式特征
The company depends on blood-center adoption, product utilization, and the expansion of pathogen-reduction systems.
生物医药行业定位
Cerus is a niche transfusion-safety company that trades on adoption and operational execution rather than drug catalysts.
未来催化剂
- Cerus’s next three months are about INTERCEPT Blood System adoption in platelets, plasma, and whole blood. The market will watch whether the company can keep converting blood-safety workflow into steady recurring demand.
近期新闻
新闻标题由机器翻译，详情为英文原文。
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。